After earnings plunge, BioNTech pins hopes on cancer drug launches
Go back to After earnings plunge, BioNTech pins hopes on cancer drug launches| (NASDAQ: BNTX) | Delayed: 91.09 +0.90 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.19 | 52 Week High | $ | |||
| Open | $90.39 | 52 Week Low | $ | |||
| Day High | $91.71 | P/E | N/A | |||
| Day Low | $90.14 | EPS | $ | |||
| Volume | 146,422 | |||||

